Study finds genomic differences between CLL an... - CLL Support
Study finds genomic differences between CLL and Richter's, multiple subtypes of the disease and the molecular pathways by which it emerges
You need to be a member of this community to see this post.
Read more about...
4 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia
Leukaemia Care is a UK charity so the support information is UK based. However the information...
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia ( CLL ) - Pseudo Richters
Several of us have reported our CLL symptoms have come roaring back after discontinuing...
Newly diagnosed with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - CLL/SLL or just found us? This post is for you!
Welcome to the CLL Support community on HealthUnlocked, a very active community with 23,000...
CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCO
Hi,
Just back from a frenetic and fantastic ASH, but still have news to share from ASCO.
But first...
With a CLL diagnosis, knowing more about your immune system could save your life!
When we are diagnosed with CLL/SLL or the precursor MBL, we need to appreciate that we are immune...
Related Posts
- YABTKi or Yet Another BTK inhibitor - an A to Z list of Bruton's Tyrosine Kinase Inhibitors and Degraders following ibrutinib's success
- Richter Transformation Survival in CLL Appears Better Among Treatment-Naive
BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'- Phase I/II trial of IPH2201 checkpoint inhibitor in combination with ibrutinib opens for patients with relapsed or refractory CLL
Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD
